![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 27112-27118, September 17, 1999
From the A. B. Hancock, Jr. Memorial Laboratory for Cancer
Research, Departments of Biochemistry and Chemistry, Center in
Molecular Toxicology, Vanderbilt Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232
The ability of the methyl-directed mismatch
repair system to recognize and repair the exocyclic adducts
propanodeoxyguanosine (PdG) and
pyrimido[1,2- Malondialdehyde (MDA)1
is produced endogenously through the processes of lipid peroxidation
and eicosanoid biosynthesis (1, 2). MDA is mutagenic in bacterial and
mammalian cell assays and carcinogenic in rodents (3-7). It also
induces p53-independent cell cycle arrest at the G1/S and
G2/M checkpoints (8). MDA reacts with DNA, forming a
pyrimidopurinone adduct to deoxyguanosine (M1G) and an
oxopropenyl adduct to deoxyadenosine
(N6-[3-(1-oxopropenyl)]deoxyadenosine)
(M1A) (Fig. 1) (9-12).
M1G also can be formed by the reaction of the oxidative DNA
damage product, base propenal, with deoxyguanosine (13).
M1G is an abundant constituent of DNA from healthy human
beings. It has been detected in several human tissues at levels from
2-150 per 108 bases (14-17). M1G may account
for a significant portion of the genotoxic and cell cycle regulatory
activity of MDA. Site-specific mutagenesis experiments indicate that
M1G induces mutations to T and A on replication in
Escherichia coli and is a block to replication (18).
Given the high biological activity of M1G, it is important
to identify the pathways by which it may be removed from DNA. We have
shown that M1G and a structural analog,
propanodeoxyguanosine (PdG), are removed in E. coli by
nucleotide excision repair and that PdG is excised by both E. coli and mammalian nucleotide excision repair complexes in
vitro (18, 19). The experiments described in the present report
were designed to test the hypothesis that M1G is recognized
by the mismatch repair system. Mismatch repair exists to correct errors
that arise during DNA replication, but recent studies indicate that it
recognizes and acts on damaged DNA, including duplexes containing
alkylated or platinated bases (20-26). In both cases, the mismatch
repair system attempts to remove the normal base opposite the adduct,
which sets up a futile cycle of repair and replication that leads to
cell toxicity. M1G and other exocyclic adducts are
relatively small adducts that resemble normal DNA bases, so they may be
substrates for removal by mismatch repair. Transfection of M13 genomes
containing single M1G or PdG adducts into E. coli strains deficient in mismatch repair suggested that both
adducts are recognized and repaired by MutS-dependent
mismatch repair. This conclusion was supported by in vitro
studies of purified MutS protein binding to M1G- and PdG-containing duplexes.
KspI was purchased from Roche Molecular Biochemicals,
and BssHII and T4 DNA ligase were from New England Biolabs
(Beverly, MA). Formamide was from Aldrich Chemical. GELase was
purchased from Epicentre Technologies (Madison, WI). T4 polynucleotide
kinase and purified MutS protein were purchased from Amersham Pharmacia Biotech. The MutS protein ran as a single band at 95 kDa on
SDS-polyacrylamide gel electrophoresis. Tris-HCl, EDTA, MOPS, calf
thymus DNA, lauryl sulfate, ATP, ADP, and nonhydrolyzable analogs were
purchased from Sigma. X-gal and
isopropyl- Bacterial Strains Used--
The E. coli strains used
in this study were JM105 (supE, tri, rpsL, endA, sbcB15, hsdR4,
Bacterial Strains and DNA Isolation--
Single-stranded
M13MB102 for the construction of M1G:C, M1G:T,
or G:C genomes was isolated as described (27). Replicative form
M13MB102 DNA was harvested using Qiagen columns (Chatsworth, CA).
E. coli strain JM105 was used as the host bacterium for the production of M13MB102 methylated DNA and for the indicator plates. E. coli strain JM110 (dam Construction of Unadducted or Adducted M13MB102 Viral
Genomes--
Construction of gapped duplex M13MB102 DNA and ligation
of adducted or unadducted 8-mers were as described previously (28). Briefly, double-stranded M13MB102 DNA was linearized with
KspI and BssHII and then dialyzed with a 12-fold
excess of single-stranded M13MB102 DNA in decreasing concentrations of
formamide. In some experiments, the single strand contained uracil in
place of thymine residues to minimize replication of the nonadducted
strand. The resultant gapped duplex DNA was isolated by a 0.8% low
melting point agarose gel run in 40 mM Tris acetate/1
mM EDTA buffer (pH 8). The gapped duplex band was excised,
and the DNA recovered using the enzyme GELaseTM, according
to the procedure provided by Epicentre Technologies. From this point
on, the use of Tris buffers was avoided because of observations that
Tris can conjugate to M1G in basic and frozen conditions
(29). M1G-, PdG-, and G-containing 8-mers (100 pmol) were
phosphorylated prior to ligation using ATP (50 µM) and T4 polynucleotide kinase in 50 mM MOPS buffer (pH 7.2). For
the ligations, gapped duplex DNA was added to each of the
phosphorylated G-, PdG-, and M1G-containing 8-mers along
with 400 units of T4 DNA ligase and ATP (1 mM). The
ligation reaction proceeded for 4 h at 16 °C in 50 mM MOPS buffer. The reaction mixtures were then brought up
to a volume of 100 µl with water, and the DNA was purified by
spinning through modified polyvinylidene difluoride membranes (Millipore). The ligation products were resolved on a 40 mM
MOPS, 0.8% low melting point agarose gel. Doubly ligated DNA was
excised from the gel and recovered using GELaseTM except
the supplied 50× Bis-Tris-NaCl buffer was not used. No additional
buffer was added. The amount of enzyme used for digestion was increased
from 1 unit of enzyme/600 mg of gel slice to 1 unit/300 mg. Formation
of G:T- and M1G:T M13MB102 DNA was the same as above except
during the formamide dialysis, a 12-fold excess of single-stranded M13MB102 was used that contained a T at position 6256.
Hemimethylated DNA was prepared similarly except the single-stranded
DNA did not contain uracil. Gapped duplex DNA with methyl groups on the
( Transformation of E. coli Cells and Determination of Mutation
Frequency and Strand Utilization--
Cells were SOS-induced and
transformed by electroporation as described previously (18). Briefly,
bacteria in logarithmic phase growth were SOS-induced with UV light
before making them competent for transformation. The UV dose was
determined by irradiating cells at increasing times from 0 to 3 min and
then plating dilutions of the irradiated cells on LB plates. The
optimal UV dose corresponded to roughly a 10% survival of the cells as
compared with no exposure. For transformation, 3 µl of DNA sample
(~25 ng/µl) was added to 20 µl of cells. The cell/DNA mixture was
placed into a chilled microelectroporation cuvette (Life Technologies,
Inc.), and the electroporations were performed at 1.5 kV/cm using a
Life Technologies, Inc. Cell-Porator E. coli electroporation
system. After electroporation, 1 ml of SOC medium was added, and the
bacteria were plated on LB plates in the presence of competent bacteria
and isopropyl-
To determine mutation frequencies, phage were eluted from the primary
transformation plates, diluted, and then replated with JM105 on
X-gal/isopropyl- In Vitro Gel Mobility Shift Assays--
( Surface Plasmon Resonance Measurements--
Surface plasmon
resonance measurements were performed using a streptavidin chip
(Amersham Pharmacia Biotech) and duplex DNA containing a 5'-biotin on
the nonadducted strand. Homo- or heteroduplex 31-mers were prepared by
heating to 80 °C and cooling to room temperature over a 3-h period,
in the presence of a 5-fold excess of the nonbiotinylated strand. All
surface plasmon resonance assays were performed using a Biacore 2000 (Amersham Pharmacia Biotech) at 25 °C in a running buffer of 0.01 M MOPS-KOH (pH 7.4), 0.15 M NaCl, 3.4 mM EDTA, 8.4 mM MgCl2, 0.008%
Surfactant P20. Each streptavidin chip was washed with 20 µl of 50 nM NaOH and each flow cell derivatized with a duplex
oligonucleotide at a flow rate of 5 µl/min, until a total binding of
approximately 60 resonance units (RU) was achieved in each flow cell.
MutS binding to the homo- or heteroduplex modified chips was assayed at
various concentrations at a flow rate of 20 µl/min, and the DNA
derivatized chips were regenerated by washing with 20 µl of 0.5%
SDS. When included, ATP, ADP, or nonhydrolyzable analogs were added to
the reaction mixture in 2-fold excess of MutS concentration.
Binding to each adduct was assayed at five different concentrations,
and sensograms were prepared for kinetic analysis by subtraction of
nonspecific binding to a G:C match. BIAEVAL 3.0 (Amersham Pharmacia
Biotech) global analysis software was employed to simultaneously fit
the association and dissociation data to a 1:1 Langmuir binding model
as described previously (31).
Detection of M1G Mutagenicity in Wild-type and Mismatch
Repair Deficient Backgrounds--
Duplex M13MB102 genomes containing
G, PdG, or M1G at position 6256 were constructed by
ligation of 8-mer oligonucleotides into gapped duplexes as described
previously. The resulting vectors were electroporated into SOS-induced
E. coli strains that were wild type or deficient in mismatch
repair, and progeny phage were probed for mutations. Single base pair
substitutions were detected by differential hybridization of plaque DNA
with radiolabeled 13-mer probes specific for each type of base pair
substitution at position 6526. It was anticipated that the involvement
of mismatch repair in the removal of M1G or PdG would
result in an increased mutation frequency in cells that were deficient
in mismatch repair. Such an effect is seen following transformation of
PdG- or M1G-containing genomes into strains deficient in
nucleotide excision repair (18).
Surprisingly, transformation of either PdG- or
M1G-containing genomes into a MutS-deficient strain led to
a decrease in mutation frequency (Table
I). Approximately a 3-fold decrease in
total mutations was observed with genomes containing PdG. The
percentage of mutations induced by M1G decreased to below
the limit of detection of the assay.
We hypothesized that the decrease in mutations observed in
mutS Mismatch Repair in Differentially Methylated DNA--
To answer
this question, we constructed hemimethylated plasmids containing PdG on
the (
To probe for PdG removal by mismatch repair, differentially methylated
genomes was transformed into uvrA-deficient cells. This was
necessary to eliminate competitive nucleotide excision repair. As
expected from previous results, the percentage of mutations observed in
the uvrA
When differentially methylated, PdG-containing genomes were transformed
into mutS MutS Binding Detection by Surface Plasmon Resonance Assay--
The
results of the in vivo experiments suggested that MutS binds
to PdG and M1G, triggering their removal by mismatch repair if the adduct-containing strand is not methylated. Therefore, we sought
to confirm the ability of MutS to bind M1G or PdG in duplex
DNA using an in vitro assay for protein-DNA interaction. Duplex 31-mers containing PdG or M1G at position 15 and C
or T opposite the adduct were synthesized and bound to a streptavidin Biacore chip by the addition of a biotin residue to the 5' terminus of
the unadducted oligonucleotide. A duplex oligonucleotide of identical
sequence but containing a G:T mismatch at position 15 was used as a control.
MutS Binding to a G:T Mismatch--
Two separate flow cells were
derivatized individually with approximately 60 RU of either
5'-biotinylated G:T duplex or G:C duplex. The binding of solutions
containing various concentrations of MutS were assessed as the
MutS-containing solutions were passed across the derivatized chips
(Fig. 3). After the binding of a 400 nM MutS solution had reached equilibrium, the binding to
the G:T duplex produced an absolute change of 616 RU (100%) compared with a change of 61 RU (9.9%) in the G:C duplex. The latter indicated a weak nonspecific interaction between MutS and the G:C duplex. This
nonspecific binding was subtracted out of all binding sensograms produced from G:T- or adduct-containing duplexes.
Binding to the G:T mismatch was assessed at various concentrations of
MutS to produce binding isotherms that were subsequently analyzed for
kinetic and thermodynamic parameters. At MutS concentrations of 50-400
nM, isotherms were globally fitted to a simple 1:1 Langmuir binding model. The BIAEVAL 3.0 program simultaneously determines kinetic association and dissociation constants from the rate of change
of response with respect to time (slope of association and dissociation
curves). The G:T mismatch had an apparent thermodynamic dissociation
constant (KD) of 18 nM. Kinetic
measurements indicated a kd of 2.44 × 10 MutS Binding to PdG and M1G Adducts--
The relative
binding of MutS to PdG and M1G adducts was assessed in a
manner similar to the G:T mismatch. Each adduct was probed at several
different concentrations of MutS, nonspecific binding was subtracted
out, and the sensograms were subjected to global kinetic analysis. As
illustrated in Fig. 4, when all adduct-containing duplexes are probed with the same concentration of
200 nM MutS, the equilibrium level of binding of MutS to
the M1G:T duplex is very close to that of a G:T mismatch
(240 RU versus 219 RU). Binding to an M1G:C
duplex gave a lower absolute response of 138 RU, and binding to both
PdG:C and PdG:T duplexes was even less significant. PdG:C showed an
equilibrium response of 85 RU, and PdG:T showed only 41 RU.
Although the thermodynamic interactions between MutS and
M1G:T or G:T duplexes are similar, Fig. 4 illustrates that
there are differences in the rates of association and dissociation. Whereas MutS binds to PdG and M1G duplexes with a
ka comparable with that of a G:T duplex,
dissociation from PdG or M1G duplexes occurs significantly
faster than dissociation from the G:T duplex. This observation is
confirmed by the kinetic and thermodynamic constants that were
extrapolated from sensogram data (Table
III). The dissociation of MutS from
M1G and PdG duplexes occurs approximately 5-fold faster
than dissociation from the G:T duplex. Because the association rates
are comparable, the lower KD for the MutS-G:T duplex
reflects the lower rate of dissociation.
MutS Binding to M1G:T in the Presence of ATP or
ADP--
Adenine nucleotide-binding sites have been found to be highly
conserved in both eukaryotic and prokaryotic MutS homologs (33). Several of the known MutS homologs fail to form complexes with mismatches in the presence of ATP by gel shift analysis. Therefore, we
attempted to use adenine nucleotide modulation as a probe for MutS-adduct binding. The oligonucleotide derivatized chips were probed
with different concentrations of MutS as above, but the buffer
contained a 2-fold excess of either ADP, ATP, or a nonhydrolyzable analog of ATP (AMP-PNP or ATP- MutS Binding to M1G and PdG Adducts by Gel Shift
Analysis--
We attempted to detect MutS binding to M1G
and PdG duplexes by gel shift analysis. Radiolabeled 31-mer
oligonucleotides containing mismatches or adducts were incubated with
increasing amounts of purified MutS protein. MutS binding to the
mismatch or adduct should retard the migration of the duplex through
the gel. Fig. 6 depicts an average band
shift experiment. Although MutS was incubated with duplexes in the
presence of excess poly(dI·dC), a small amount of nonspecific binding
was detected and was used as background for comparison with mismatch
and adduct binding. Incubation of a G:T duplex with increasing amounts
of MutS protein resulted in a strong gel shift, consistent with
previous reports. The presence of MutS was required for detection of
this shift. MutS incubation with a duplex containing M1G:T
produced a shift above background levels. Significant binding was
detected at concentrations as low as 200 nM. Incubation of
MutS with M1G:C showed only a small amount of binding that
was not far above background levels, and incubation with a PdG:C or
PdG:T containing duplex did not yield any band shift. The results of
these gel shift experiments are consistent with the results of the
surface plasmon resonance experiments.
The present study provides in vivo and in
vitro evidence that M1G and PdG are recognized by MutS
and that they can be repaired by methyl-directed mismatch repair when
the genome is not methylated on the adduct-containing strand. The
interaction with MutS appears to be competitive with binding and repair
of the adducts by nucleotide excision repair. Thus, when
M1G and PdG are introduced on vectors methylated on both
strands, they are not repaired by mismatch repair but are protected
against nucleotide excision repair. Conversely, when mutS is
deleted, the adducts are efficiently repaired by nucleotide excision
repair resulting in a significant reduction in mutations relative to
wild type. To probe for the binding of MutS to PdG and M1G
in vitro, we employed a surface plasmon resonance assay and
a gel mobility shift assay. The surface plasmon resonance assay
provided kinetic and thermodynamic data for the protein-nucleic acid
interaction. The dissociation constant for MutS binding to the G:T
duplex was very similar to the value determined previously by gel shift
analysis (32). Binding isotherms illustrated that the affinity for
M1G:T was similar to that for G:T, but its affinity for
M1G:C, PdG:C, and PdG:T was lower. Furthermore, the
dissociation rates for MutS release from each of these adducts were
approximately 10-fold faster than the dissociation rate from G:T.
MutS binding to G:T and M1G:T duplexes also was detected by
gel mobility shift analysis, but binding to M1G:C, PdG:T or
PdG:C was not. We attribute this to the lower affinity of MutS for
these duplexes and their higher dissociation rates as measured by
surface plasmon resonance. These experiments illustrate the utility of surface plasmon resonance for detection of rapidly reversible protein-nucleic acid interactions. Although the kinetics of
dissociation of MutS from M1G- and PdG-containing duplexes
are rapid, the extent of binding is sufficient to protect
M1G- or PdG-adducted genomes from nucleotide excision
repair or to initiate methyl-directed mismatch repair as judged by the
in vivo data. MutS binding to these genomes in
vivo may be stabilized by the larger size of the genome relative
to the 31-mer oligonucleotides used for the in vitro
experiments or by binding to additional protein factors.
Although mismatch repair exists to remove errors made during DNA
replication, the system does recognize and attempt to repair other DNA
adducts. For example, MutS binds to
O6-methylguanine and attempts to repair the
strand opposite it (23). This leads to a futile cycle of removal and
resynthesis that eventually causes cell death. A similar effect is
observed with DNA containing G-G intrastrand cross-links induced by
cis-platinum (35, 36). The attempted repair of these lesions
or protection from nucleotide excision repair provided by MutS binding
is important to the therapeutic activity of methylating agents and
cis-platinum. Tumor cells that have lost mismatch repair
capability are more resistant to the cytotoxic action of both
alkylating agents and cis-platinum (37, 38). In fact, high
levels of expression of the mismatch repair system appear to be an
important determinant of the efficacy of cis-platinum
against testicular tumors (39).
The affinity of MutS for M1G and PdG duplexes is comparable
with that of MutS for the cis-platinum intrastrand G-G
cross-link (23-107 nM versus 67 nM,
respectively) (35). The latter value was measured by gel mobility shift
analysis, which suggests that the dissociation rate of MutS from the
cis-platinum adduct is lower than that from M1G
or PdG. However, the affinity is strongly dependent on the base
opposite the modified guanines. For example, no binding of human MutS
to a cis-platinum adduct is observed when the base opposite
each of the modified Gs is C or when the base opposite the 5' G is T
(40). However, binding is optimal when the base opposite the 3' G is T. In our hands, MutS binds twice as strongly to M1G:T
relative to M1G:C. This is further support for the
observation that the base opposite the damaged DNA base is an important
determinant of MutS binding.
An added feature of the binding of MutS to M1G is the
chemical structure of the M1G as a function of the base
opposite it. We have recently shown that M1G undergoes
rapid and quantitative ring opening to
N2-(3-oxopropenyl)-deoxyguanosine when
present in a duplex DNA opposite C (Scheme
1) (41). Ring opening is reversed when
the duplex is heat-denatured. No ring opening is detected when
M1G is placed in duplexes opposite T. Thus, the reduced
affinity of MutS for M1G:C duplexes may be a result of the
presence of the ring-opened form of M1G in this duplex.
MutS Recognition of Exocyclic DNA Adducts That Are Endogenous
Products of Lipid Oxidation*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
]purin-10(3H)-one
(M1G), the major adduct derived from the endogenous
mutagen malondialdehyde, has been assessed both in vivo and
in vitro. Both adducts were site-specifically incorporated
into M13MB102 DNA, and the adducted genomes were electroporated into
wild-type or mutS-deficient Escherichia coli strains. A decrease in mutations caused by both adducts was observed in
mutS-deficient strains, suggesting that MutS was binding to the adducts and blocking repair by nucleotide excision repair. This
hypothesis was supported by the differences in mutation frequency observed when hemimethylated genomes containing PdG on the (
)-strand were electroporated into a uvrA
strain. The
ability of purified MutS to bind to PdG- or M1G-containing 31-mer duplexes in vitro was assessed using both surface
plasmon resonance and gel shift assays. MutS bound to
M1G:T-containing duplexes with similar affinity to a G:T
mismatch but less strongly to M1G:C- and PdG-containing
duplexes. Dissociation from each of the adduct-containing duplexes
occurred at a faster rate than from a G:T mismatch. The present results
indicate that MutS can bind to exocyclic adducts resulting from
endogenous DNA damage and trigger their removal by mismatch repair or
protect them from removal by nucleotide excision repair.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (9K):
[in a new window]
Fig. 1.
Structures of MDA-DNA adducts and PdG, a
model for M1G.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactoside were from Gold
Biotechnology (St. Louis, MO). Nitrocellulose transfer membranes (BA85,
82.5-mm diameter) were purchased from Schleicher & Schuell. Ultrafree
probind filters (0.45 µm) were from Millipore (Bedford, MA).
[
-32P]ATP (10 mCi/ml) was from NEN Life Science
Products. Unadducted and PdG-adducted 8-mer oligonucleotides used in
mutagenesis experiments, 5'-GGTXTCCG-3' (X = G, PdG), and 31-mer oligonucleotides used for gel shift and surface
plasmon resonance assays
5'-GACGAATTCGCGATCXTCGACTCGAGCTCAG-3' were synthesized by
Midland Certified Reagent Company (Midland, TX) and ran as single bands
on a 20% polyacrylamide gel. The M1G-adducted oligonucleotides were synthesized, purified, and characterized as
described. Following purification, the M1G oligonucleotides were determined to be 99.7% pure by 20% polyacrylamide gel
electrophoresis. For the surface plasmon resonance assays, duplexes
were 5'-biotinylated by phosphoramidite chemistry on the nonadducted
strand. Oligonucleotides used as hybridization probes were prepared
using an Applied Biosystems (Foster City, CA) automated DNA synthesizer
in the Vanderbilt University Center in Molecular Toxicology Molecular
Genetics Core and purified using a SurePureTM
oligonucleotide purification kit from Amersham Pharmacia Biotech.
(lac-proAB) [F' traD36, proAB, lacIQ
Z
M15]) and several derivatives of AB1157 (thr-1, ara-14,
leuB6,
(gpt-proA)62, lacY1, tsx-33, supE44, galK2,

, rac
, hisG4,
rfbD1, mgl-51, rpsL31, kdgK51, xyl-5, mtl-1, argE3, thi-1). These
included LM102 (AB1157; [F', traD36, proAB,
lacIQZ
M15]), LM107 (RK1517; [F', traD36,
proAB, lacIQZ
M15]), and LM119 (RPC501; [F',
traD36, proAB lacIQZ
M15]). LM102, LM107, and LM119
were constructed as described previously (18). RK1517 (AB1157; but
mutS201::Tn5) and RPC501 (AB1157;
nfo-1::kan, D(xth-pncA)90)
were generous gifts from P. Modrich (Duke University, Durham, NC) and
R. Cunningham (SUNY, Albany, NY), respectively.
) was used
as the host bacterium for the production of unmethylated M13MB102 in
hemimethylated genome studies.
)-strand was prepared by formamide dialysis of methylated linear
M13MB102 and unmethylated single-stranded M13MB102 DNA. Gapped duplex
DNA with methyl groups on the (+)-strand was prepared by formamide
dialysis of unmethylated linear M13MB102 and methylated single-stranded
M13MB102 DNA.
-D-thiogalactoside and allowed to grow overnight.
-D-thiogalactoside indicator plates to
give roughly 300 plaques/plate. The plaques on the secondary plates
were then lifted using nitrocellulose membranes and probed for base
pair substitution mutations at position 6256 by differential hybridization with 13-mer probes. Membranes from 12 modified phage plates and 12 unmodified phage plates were split evenly into four dishes. Each dish contained one of the four probes. Because there was
only one lift/plate and not four identical lifts with one membrane
being placed into each dish, the summation of mutations detected along
with G hybridizations sometimes did not add up to 100%. The
specificity of the probes for a 1-base change at position 6256 has been
shown previously (28, 30).
)-Strand
oligonucleotides were phosphorylated with 10 µCi of
[
-32P]ATP using 10 units of T4 polynucleotide kinase
and 5 µl of kinase dilution buffer. The reaction was incubated at
37 °C for 30 min and then heated to 70 °C for 10 min to
inactivate the enzyme. The labeled oligonucleotide was purified by
elution from a G50 microspin (Amersham Pharmacia Biotech) column and
annealed to a 5-fold excess of its unlabeled complementary strand. All
binding reactions were carried out in 20-µl incubations on ice. 10 µl of 0-400 nM purified MutS protein was added to 5 µl
(0.8 pmol/µl) of labeled oligonucleotide and 5 µl of reaction
buffer (0.01 M MOPS-KOH, pH 7.4, 0.15 M NaCl,
8.4 mM MgCl2, 3.4 mM EDTA, 10 ng/µl poly(dI·dC), 15% glycerol). Reactions were incubated on ice
for 15 min, before loading onto a 4% polyacrylamide, 4% glycerol gel with a 40 mM MOPS, 1 mM MgCl2
buffer run at constant voltage of 200 V for 2.5 h. Gels were then
dried and analyzed using a 400E PhosphorImager (Molecular Dynamics,
Sunnydale, CA).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Effect of mismatch repair deficiency on the induction of mutations by
PdG or M1G
cells is due to competitive binding of
MutS and the uvrA2B complex to the adducts but repair only
by the nucleotide excision complex (Fig.
2). MutS cannot initiate repair because
both the (+)- and (
)-strands of M13MB102 are methylated. Thus, in a
wild-type cell, MutS protects the adduct from repair by uvr(A)BC. In
the (uvrA
) strain, only MutS is present, so
repair is not initiated, and the mutation frequency is increased
3-4-fold because of the prolonged half-life of the adduct. However, in
the mutS
strain, uvr(A)BC is able to repair
the adduct, and a decreased mutation frequency is observed. These
observations and the hypothesis to explain them raise the question of
whether the mismatch repair system is capable of removing PdG or
M1G.

View larger version (12K):
[in a new window]
Fig. 2.
Competitive binding of PdG by MutS and
UvrA2B. In the wild-type strain, both MutS and
UvrA2B bind PdG, but only the UvrA(B)C complex repairs the
adduct. In the uvrA
strain, only MutS is
present so the repair of PdG decreases and the mutation frequency
increases. In the mutS
strain, there is no
competition between binding of UvrA2B and binding of MutS.
Repair of PdG by UvrA(B)C increases, thus decreasing the mutation
frequency.
)-strand and methyl groups on either the (+)- or (
)-strand.
Methylated single-stranded or double-stranded M13MB102 was isolated
from JM105 (dam+), and unmethylated single- or
double-stranded DNA was isolated from JM110
(dam
). Hemimethylated DNA was prepared by
formamide dialysis, and gapped duplex DNA was prepared with methyl
groups placed selectively on the (+)- or (
)-strand. Hemimethylated,
adducted plasmids were transformed into E. coli, and the
percentage of base pair substitutions at position 6526 was determined.
The frequency of PdG
A transitions and PdG
T transversions were
equivalent in all strains tested, so the total percentage of mutations
is reported for simplicity. The percentage of base pair substitutions
observed in JM105 (wt) was 1.5% when PdG was on the methylated strand
and 1.0% and 1.1% when the strand opposite PdG was methylated or both
strands were methylated (Table II). A
similar percentage of mutations was observed in LM102. The lower
mutation frequencies recorded in these experiments relative to those
summarized in Table I resulted from the absence of uracil residues in
the (+)-strand in the experiments summarized in Table II. The presence
of uracil residues in the (+)-strand lowers the replication of the
(+)-strand and increases the detection of mutations induced by adducts
on the (
)-strand.
Effect of methylation status on mutation frequency
background was 3-4-fold higher when
methyl groups were present on the PdG-containing strand or on both
strands. In contrast, the percentage of mutations was much lower when
methyl groups were present on the strand opposite PdG. This is
consistent with removal of PdG by the methyl-directed mismatch repair system.
cells, a decrease in mutations
comparable with that reported in Table I was observed regardless of the
methylation status of the genome. This suggests that removal of PdG by
nucleotide excision repair is not sensitive to the presence of methyl
groups on either the adducted or nonadducted strand.

View larger version (13K):
[in a new window]
Fig. 3.
Specificity of binding of MutS to G:T
mismatch. Homo- or heteroduplexes containing a G:T mismatch were
created by annealing a 5-fold excess of the nonbiotinylated strand to
the 5'-biotinylated strand. DNA (60 RU) was immobilized on a
streptavidin surface in separate flow cells of a Biacore chip.
A, a saturating amount of MutS protein (50 µl, 400 nM) was washed over each flow cell at a flow rate of 20 µl/min before the protein was washed off with 20 µl of 0.5% SDS
(not shown). B, the bulk refractive index contribution from
buffer solution was subtracted from sensograms to display the low level
of nonspecific binding to the G:C homoduplex.
3 s
1 and ka of
1.36 × 105 M
1 s
1
with a chi square value of 1.10, falling well within accepted statistical values for Biaeval 3.0 analysis. These thermodynamic constants compare favorably with a KD of 20 ± 5 nM determined by DNA footprinting and gel shift analysis
(32).

View larger version (25K):
[in a new window]
Fig. 4.
Comparative binding of MutS to G:T as well as
M1G and PdG adducts. Biotinylated 31-mer duplexes (60 RU) containing G:T, M1G:T, M1G:C, PdG:C, or
PdG:T were immobilized in separate flow cells. MutS (50 µl, 200 nM) was passed across each flow cell at a flow rate of 20 µl/min. Bulk refractive index contributions and nonspecific binding
to a G:C homoduplex were subtracted from each sensogram prior to
quantitative analysis.
Kinetic and thermodynamic parameters of MutS binding to M1G-
and PdG-containing duplexes
-S) with respect to MutS. As
demonstrated in Fig. 5, the extent of
binding of MutS to the M1G:T duplex is significantly
reduced in the presence of ATP. In contrast, addition of ADP appeared
to stabilize the interaction between MutS and the M1G:T
duplex, denoted on the sensogram by a slower rate of dissociation of
the MutS from the oligonucleotide surface.

View larger version (19K):
[in a new window]
Fig. 5.
Binding of MutS to M1G:T in the
presence of ATP or ADP. M1G:T-containing duplexes were
immobilized (60 RU) on a streptavidin sensor surface through a
5'-biotin molecule on the adducted strand. A saturating concentration
of MutS (50 µl, 200 nM) containing no nucleotide, 400 nM ATP, or 400 nM ADP were passed over the flow
cell surface, and comparative binding was assessed after subtraction of
nonspecific G:C binding. The binding isotherms show both association
and dissociation phases. Bulk refractive index contributions and
nonspecific binding to a G:C homoduplex were subtracted from each
sensogram prior to quantitative analysis.

View larger version (48K):
[in a new window]
Fig. 6.
Gel shift analysis of MutS binding to a
M1G:T duplex. Duplex 31-mers were created by
5'-phosphorylation of the adducted strand with
[
-32P]ATP and annealing to a 5-fold excess of the
unlabeled strand. Purified MutS protein (0-400 nM, 10 µl) was added to 5 µl (0.8 pmol/µl) and 5 µl of reaction buffer
(0.01 M MOPS-KOH, pH 7.4, 0.15 M NaCl, 8.4 mM MgCl2, 3.4 mM EDTA, 10 ng/µl
poly(dI·dC), 15% glycerol), and the reactions were incubated on ice
for 15 min, before loading onto a 4% nondenaturing polyacrylamide gel
with a 40 mM MOPS, 1 mM MgCl2
buffer. Gels were then analyzed by a PhosphorImager.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (14K):
[in a new window]
Scheme 1.
Transformations of M1G
in DNA.
This and previous studies establish that some overlap exists between
the repair of small DNA adducts by global repair systems such as
nucleotide excision repair and mismatch repair. Furthermore, binding of
MutS to small lesions, even in the absence of subsequent repair, can
protect these lesions from removal by nucleotide excision repair.
M1G is among the most abundant exocyclic adducts found in
the DNA of healthy humans (17). Its formation is linked to polyunsaturated fatty acid metabolism through lipid peroxidation or
prostaglandin biosynthesis. Indeed, women consuming diets rich in
polyunsaturated fatty acids exhibit a 10-20-fold increase in the level
of M1G in leukocyte DNA (34). It will be interesting to
determine whether the levels of M1G in human tissue are
sensitive to conditions that increase or decrease the levels of
mismatch repair proteins (e.g. hereditary nonpolyposis
colorectal cancer).
| |
ACKNOWLEDGEMENT |
|---|
We are grateful to R. Mernaugh for assistance with surface plasmon resonance measurements and for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant CA47479. Core facilities were supported by NIEHS, National Institutes of Health Grant ES00267 and NCI, National Institutes of Health Grant CA68485.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Chemistry Dept., University of Wisconsin-Madison,
Madison, WI 53706.
§ Present address: Case Western Reserve University, Suite 200, Lab I, UCRC2, 11001 Cedar Rd., Cleveland, OH 44106.
¶ To whom correspondence should be addressed. Tel.: 615-343-7329; Fax: 615-343-7534; E-mail: marnett@toxicology.mc.vanderbilt.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
MDA, malondialdehyde;
M1G, pyrimido[1,2-
]purin-10(3H)-one;
PdG, 1,N2-propano-2'-deoxyguano-sine;
RU, resonance unit;
MOPS, 4-morpholinepropanesulfonic acid;
AMP-PNP, 5'-adenylylimidodiphosphate;
ATP-
-S, adenosine
5'-O-(thiotriphosphate);
X-gal, 5-bromo-4-chloro-3-indolyl-
-D-
galactopyranoside.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bernheim, F.,
Bernheim, M. L. C.,
and Wilbur, K. M.
(1948)
J. Biol. Chem.
174,
257-264 |
| 2. |
Hamberg, M.,
and Samuelsson, B.
(1967)
J. Biol. Chem.
242,
5344-5354 |
| 3. |
Mukai, F. H.,
and Goldstein, B. D.
(1976)
Science
191,
868-869 |
| 4. |
Basu, A. K.,
and Marnett, L. J.
(1983)
Carcinogenesis
4,
331-333 |
| 5. | Yau, T. M. (1979) Mech. Ageing Dev 11, 137-144[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Benamira, M.,
Johnson, K.,
Chaudhary, A.,
Bruner, K.,
Tibbetts, C.,
and Marnett, L. J.
(1995)
Carcinogenesis
16,
93-99 |
| 7. | Spalding, J. W. (1988) NTP Technical Report 331 5-13 |
| 8. | Ji, C., Rouzer, C. A., Marnett, L. J., and Pietenpol, J. A. Carcinogenesis 19, 1275-1283 |
| 9. | Seto, H., Akiyama, K., Okuda, T., Hashimoto, T., Takesue, T., and Ikemura, T. (1981) Chem. Lett. XX, 707-708[CrossRef] |
| 10. | Basu, A. K., O'Hara, S. M., Valladier, P., Stone, K., Mols, O., and Marnett, L. J. (1988) Chem. Res. Toxicol. 1, 53-59[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Nair, V., Turner, G. A., and Offerman, R. J. (1984) J. Am. Chem. Soc. 106, 3370-3371[CrossRef] |
| 12. | Stone, K., Ksebati, M., and Marnett, L. J. (1990) Chem. Res. Toxicol. 3, 33-38[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Dedon, P. C.,
Plastaras, J. P.,
Rouzer, C. A.,
and Marnett, L. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11113-11116 |
| 14. |
Chaudhary, A. K.,
Nokubo, M.,
Reddy, G. R.,
Yeola, S. N.,
Morrow, J. D.,
Blair, I. A.,
and Marnett, L. J.
(1994)
Science
265,
1580-1582 |
| 15. |
Fang, J.-L.,
Vaca, C. E.,
Valsta, L. M.,
and Mutanen, M.
(1996)
Carcinogenesis
17,
1035-1040 |
| 16. |
Leuratti, C.,
Singh, R.,
Lagneau, C.,
Farmer, P. B.,
Plastaras, J. P.,
Marnett, L. J.,
and Shuker, D. E.
(1998)
Carcinogenesis
19,
1919-1924 |
| 17. | Marnett, L. J. (1999) Mutat. Res. 424, 83-95[Medline] [Order article via Infotrieve] |
| 18. |
Fink, S. P.,
Reddy, G. R.,
and Marnett, L. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8652-8657 |
| 19. |
Johnson, K. A.,
Fink, S. P.,
and Marnett, L. J.
(1997)
J. Biol. Chem.
272,
11434-11438 |
| 20. | Modrich, P., and Lahue, R. (1996) Annu. Rev. Biochem. 65, 101-133[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Jiricny, J. (1998) Mutat. Res. 409, 107-121[Medline] [Order article via Infotrieve] |
| 22. |
Fishel, R.
(1998)
Genes Dev.
12,
2096-2101 |
| 23. | Karran, P., and Marinus, M. G. (1982) Nature 296, 868-869[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Liu, L.,
Markowitz, S.,
and Gerson, S. L.
(1996)
Cancer Res
56,
5375-5379 |
| 25. | Ferry, K. V., Fink, D., Johnson, S. W., Nebel, S., Hamilton, T. C., and Howell, S. B. (1999) Biochem. Pharmacol. 57, 861-867[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Vaisman, A.,
Varchenko, M.,
Umar, A.,
Kunkel, T. A.,
Risinger, J. I.,
Barrett, J. C.,
Hamilton, T. C.,
and Chaney, S. G.
(1998)
Cancer Res.
58,
3579-3585 |
| 27. | Benamira, M., and Marnett, L. J. (1993) Chem. Res. Toxicol. 6, 317-327[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Burcham, P. C.,
and Marnett, L. J.
(1994)
J. Biol. Chem.
269,
28844-28850 |
| 29. | Neidernhofer, L. J., Riley, M., Schnetz-Boutaud, N., Sanduwaran, G., Chaudhary, A. K., Reddy, G. R., and Marnett, L. J. (1997) Chem. Res. Toxicol. 10, 556-561[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Benamira, M.,
Singh, U. S.,
and Marnett, L. J.
(1992)
J. Biol. Chem.
267,
22392-22400 |
| 31. | Babic, I., Andrew, S. E., and Jirik, F. R. (1996) Mutat. Res. 372, 87-96[Medline] [Order article via Infotrieve] |
| 32. | Gradia, S., Acharya, S., and Fishel, R. (1997) Cell 91, 995-1005[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951[Medline] [Order article via Infotrieve] |
| 34. | Nair, J., Vaca, C. E., Velic, I., Mutanen, M., Valsta, L. M., and Bartsch, H. (1997) Cancer Epidemiol. Biomarkers Prev. 6, 597-601[Abstract] |
| 35. | Mu, D., Tursun, M., Duckett, D. R., Drummond, J. T., Modrich, P., and Sancar, A. (1997) Mol. Cell. Biol. 17, 760-769[Abstract] |
| 36. | Fram, R. J., Cusick, P. S., Wilson, J. M., and Marinus, M. G. (1985) Mol. Pharmacol. 28, 51-55[Abstract] |
| 37. | Levati, L., Marra, G., Lettieri, T., D'Atri, S., Vernole, P., Tentori, L., Lacal, P. M., Pagani, E., Bonmassar, E., Jiricny, J., and Graziani, G. (1998) Genes Chromosomes 23, 159-166 |
| 38. |
Fink, D.,
Nebel, S.,
Aebi, S.,
Zheng, H.,
Cenni, B.,
Nehme, A.,
Christen, R. D.,
and Howell, S. B.
(1996)
Cancer Res
56,
4881-4886 |
| 39. | Mello, J. A., Acharya, S., Fishel, R., and Essigman, J. M. (1996) Chem. Biol. 3, 579-589[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Yamada, M.,
O'Regan, E.,
Brown, R.,
and Karran, P.
(1997)
Nucleic Acids Res.
25,
491-495 |
| 41. |
Mao, H.,
Schnetz-Boutaud, N. C.,
Weisenseel, J. P.,
Marnett, L. J.,
and Stone, M. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6615-6620 |
This article has been cited by other articles:
![]() |
S. D. Cline, J. N. Riggins, S. Tornaletti, L. J. Marnett, and P. C. Hanawalt Malondialdehyde adducts in DNA arrest transcription by T7 RNA polymerase and mammalian RNA polymerase II PNAS, May 11, 2004; 101(19): 7275 - 7280. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. VanderVeen, M. F. Hashim, Y. Shyr, and L. J. Marnett Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde PNAS, November 25, 2003; 100(24): 14247 - 14252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Niedernhofer, J. S. Daniels, C. A. Rouzer, R. E. Greene, and L. J. Marnett Malondialdehyde, a Product of Lipid Peroxidation, Is Mutagenic in Human Cells J. Biol. Chem., August 15, 2003; 278(33): 31426 - 31433. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fourrier, P. Brooks, and J.-M. Malinge Binding Discrimination of MutS to a Set of Lesions and Compound Lesions (Base Damage and Mismatch) Reveals Its Potential Role as a Cisplatin-damaged DNA Sensing Protein J. Biol. Chem., May 30, 2003; 278(23): 21267 - 21275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh, C. Leuratti, S. Josyula, M. A. Sipowicz, B. A. Diwan, K. S. Kasprzak, H. A. J. Schut, L. J. Marnett, L. M. Anderson, and D. E. G. Shuker Lobe-specific increases in malondialdehyde DNA adduct formation in the livers of mice following infection with Helicobacter hepaticus Carcinogenesis, August 1, 2001; 22(8): 1281 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Hardman, C. A. Afshari, and J. C. Barrett Involvement of Mammalian MLH1 in the Apoptotic Response to Peroxide-induced Oxidative Stress Cancer Res., February 1, 2001; 61(4): 1392 - 1397. [Abstract] [Full Text] |
||||
![]() |
P. Sachadyn, A. Stanisawska, and J. Kur One tube mutation detection using sensitive fluorescent dyeing of MutS protected DNA Nucleic Acids Res., April 15, 2000; 28(8): e36 - e. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Marnett Oxyradicals and DNA damage Carcinogenesis, March 1, 2000; 21(3): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
| ||||||||